Global /Egypt /Healthcare /Drug Manufacturers - General /ADCI

The Arab Drug Co.

ADCI

• EGX: ADCI • Delayed

178.19EGP -0.1%

3.44 USD

As of 7 June 2026, The Arab Drug Co. has a market cap of $41.26M USD, ranking #31941 globally and #137 in Egypt. It ranks #2883 in the Healthcare sector, and #1002 in the Drug Manufacturers - General industry.

Global Rank

31941

Country Rank

137

Sector Rank

2883

Industry Rank

1002

Key Stats

Market Cap

$41.26MUSD

2.14B EGP

Enterprise Value

$50.23MUSD

2.6B EGP

Revenue (TTM)

$23.81MUSD

1.23B EGP

EBITDA (TTM)

$497.26MUSD

25.74B EGP

Net Income (TTM)

$4.35MUSD

225.52M EGP

EBITDA Margin

2K%

Profit Margin

21%

PE Ratio

9.5

PS Ratio

1.7

PB Ratio

3.4

EV/EBITDA

0.1

Company Profile

Country (HQ)

Egypt

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Ahmed Ali open_in_new

Employees

1,148

Founded

1963

Website

adcopharma-eg.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.1%	-3.1%	21%	12%	-28%	-17%	122%	494%	432%

News

Markets

Exchange	Ticker	Price	Quotes
Egyptian Exchange (EGX) MIC: XCAI PRIMARY	ADCI العربية للادوية والصناعات الكيماوية ISIN: EGS38321C013 Shares Out.: Shares Outstanding: 12.0M¹ TV: TradingView: EGX: ADCI SA: Stock Analysis: EGX: ADCI YF: Yahoo Finance: ADCI GF: Google Finance: EGX: ADCI BA: Barron's: ADCI MS: Morningstar: XCAI: ADCI	178.19 EGP	TV: TradingView: EGX: ADCI SA: Stock Analysis: EGX: ADCI YF: Yahoo Finance: ADCI GF: Google Finance: EGX: ADCI BA: Barron's: ADCI MS: Morningstar: XCAI: ADCI

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About The Arab Drug Co.

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

Similar Companies

Industry: Drug Manufacturers - General (Egypt)

Name	Market Cap (USD) diff.	PE	Country
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) EGX: RMDA	$175.61M 9.1B EGP 326%	34.1	Egypt
MINAPHARM Pharmaceuticals EGX: MIPH	$135.46M 7.02B EGP 228%	58.9	Egypt
EI- Nile Co. for Pharmaceuticals and Chemical Industries EGX: NIPH	$119.84M 6.21B EGP 190%	27.1	Egypt
Kahira Pharmaceuticals & Chemical Industries Co. EGX: CPCI	$90.34M 4.68B EGP 119%	10.0	Egypt
Alexandria Co. For Pharmaceuticals & Chemical Industries EGX: AXPH	$86.21M 4.47B EGP 109%	9.0	Egypt
Memphis Pharmaceuticals & Chemical Industries EGX: MPCI	$74.87M 3.88B EGP 81%	7.5	Egypt

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 1M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 874K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 787K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 701K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 672K%	20.5	Switzerland

chevron_leftBack